Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 32.94%213.21M | 16.88%187.39M | -5.07%167.1M | -6.91%730.06M | -1.56%233.34M | -6.10%160.37M | -18.82%160.33M | -1.65%176.02M | -7.85%784.29M | 34.16%237.03M |
| Cost of revenue | 27.39%172.55M | 12.77%152.18M | -15.97%132.86M | -11.21%599.09M | -14.79%170.77M | -5.99%135.45M | -26.61%134.94M | 8.02%158.1M | -5.75%674.73M | 40.20%200.4M |
| Gross profit | 63.14%40.66M | 38.69%35.21M | 91.12%34.24M | 19.54%130.97M | 70.83%62.57M | -6.64%24.92M | 86.18%25.39M | -45.05%17.92M | -18.95%109.56M | 8.57%36.63M |
| Operating expense | 12.09%5.16M | 8.52%5.01M | 13.76%5.03M | -18.39%7.09M | -18.72%6.37M | 21.31%4.6M | 27.09%4.61M | 19.59%4.42M | 226.39%8.69M | 142.56%7.83M |
| Selling and administrative expenses | 12.09%5.16M | 8.52%5.01M | 13.76%5.03M | 8.25%20.51M | -18.72%6.37M | 21.31%4.6M | 27.09%4.61M | 19.59%4.42M | -1.29%18.95M | 2.09%7.83M |
| -Selling and marketing expense | -51.58%46K | -6.82%82K | -34.74%62K | 6.85%359K | -19.00%81K | 35.71%95K | 49.15%88K | -11.21%95K | 46.72%336K | -34.21%100K |
| -General and administrative expense | 13.43%5.11M | 8.82%4.92M | 14.82%4.97M | 8.27%20.15M | -18.71%6.29M | 21.04%4.5M | 26.72%4.52M | 20.51%4.33M | -1.87%18.61M | 2.82%7.73M |
| Other operating expenses | ---- | ---- | ---- | -179.76%-851K | ---- | ---- | ---- | ---- | 13,437.50%1.07M | ---- |
| Total other operating income | ---- | ---- | ---- | 10.99%12.57M | ---- | ---- | ---- | ---- | -56.56%11.32M | ---- |
| Operating profit | 74.70%35.51M | 45.38%30.2M | 116.46%29.21M | 22.80%123.87M | 95.19%56.2M | -11.27%20.33M | 107.60%20.78M | -53.31%13.5M | -28.99%100.87M | -44.77%28.8M |
| Net non-operating interest income (expenses) | 227.84%318K | 135.86%467K | 110.07%313K | 140.58%502K | 164.77%57K | 137.16%97K | 150.90%198K | 129.86%149K | 50.52%-1.24M | 83.76%-88K |
| Non-operating interest income | 9.25%1.11M | -0.69%1.16M | 1.60%1.14M | 96.92%4.41M | 26.87%1.11M | 48.97%1.02M | 150.65%1.16M | 406.31%1.12M | 90.07%2.24M | 231.18%871K |
| Non-operating interest expense | -13.82%792K | -28.70%688K | -14.97%829K | 12.40%3.91M | 9.28%1.05M | -2.55%919K | 13.13%965K | 35.23%975K | -5.49%3.48M | 19.13%959K |
| Net investment income | 310.66%4.65M | -173.33%-2.21M | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | -255.10%-4.05M | 558.59%2.61M | ||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 119.03%78.27M | 35.74M | ||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 160.21%1.9M | -9.99%-3.15M | ||||||||
| Less:Impairment of capital assets | ---- | ---- | ---- | -152.02%-1.68M | ---- | ---- | ---- | ---- | -21.82%3.22M | ---- |
| Less:Other special charges | ---- | ---- | ---- | -201.37%-220K | ---- | ---- | ---- | ---- | 94.74%-73K | ---- |
| Less:Write off | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non-operating income (expenses) | 125.08%72.87M | -383.79%-56.79M | -6.33%6.35M | 20.00%168K | -3.44%34.85M | 330.43%32.38M | 625.06%20.01M | 88.90%6.77M | 8.53%140K | 242.36%36.09M |
| Income before tax | 105.87%108.7M | -163.73%-26.12M | 75.67%35.87M | 54.64%205.31M | 40.61%91.11M | 75.02%52.8M | 605.75%40.98M | -36.18%20.42M | -5.32%132.76M | 141.90%64.79M |
| Income tax | 80.47%9.93M | 35.81%7.74M | 95.47%7.81M | 25.03%30.39M | 73.84%15.19M | 3.36%5.5M | 102.63%5.7M | -46.21%4M | -23.75%24.31M | 1,406.21%8.74M |
| Net income | 108.83%98.77M | -195.98%-33.86M | 70.85%28.06M | 61.28%174.92M | 35.43%75.92M | 90.38%47.3M | 1,078.78%35.28M | -33.14%16.42M | 0.10%108.46M | 113.88%56.06M |
| Net income continuous operations | 108.83%98.77M | -195.98%-33.86M | 70.85%28.06M | 61.28%174.92M | 35.43%75.92M | 90.38%47.3M | 1,078.78%35.28M | -33.14%16.42M | 0.11%108.46M | 113.91%56.06M |
| Net income discontinuous operations | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Noncontrolling interests | 194.74%56K | -25.53%35K | -55.17%13K | 0.86%117K | 195.65%22K | -36.67%19K | 11.90%47K | -56.72%29K | -59.58%116K | -135.94%-23K |
| Net income attributable to the company | 108.80%98.71M | -196.20%-33.9M | 71.08%28.04M | 61.35%174.8M | 35.34%75.9M | 90.53%47.28M | 1,093.97%35.23M | -33.08%16.39M | 0.26%108.34M | 114.49%56.08M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 108.80%98.71M | -196.20%-33.9M | 71.08%28.04M | 61.35%174.8M | 35.34%75.9M | 90.53%47.28M | 1,093.97%35.23M | -33.08%16.39M | 0.26%108.34M | 114.49%56.08M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 109.76%0.043 | -196.73%-0.0148 | 71.83%0.0122 | 61.49%0.0759 | 35.80%0.033 | 89.81%0.0205 | 1,076.92%0.0153 | -33.02%0.0071 | 0.64%0.047 | 113.16%0.0243 |
| Diluted earnings per share | 109.76%0.043 | -196.73%-0.0148 | 71.83%0.0122 | 61.49%0.0759 | 35.80%0.033 | 89.81%0.0205 | 1,076.92%0.0153 | -33.02%0.0071 | 0.64%0.047 | 113.16%0.0243 |
| Dividend per share | 0 | 0.015 | 0 | 0.00%0.01 | 0.005 | 0 | 0 | 0.005 | -50.00%0.01 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.